These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16373709)

  • 1. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy.
    Ali S; El-Rayes BF; Sarkar FH; Philip PA
    Mol Cancer Ther; 2005 Dec; 4(12):1943-51. PubMed ID: 16373709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Ali S; Banerjee S; Ahmad A; El-Rayes BF; Philip PA; Sarkar FH
    Mol Cancer Ther; 2008 Jun; 7(6):1708-19. PubMed ID: 18566242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.
    El-Rayes BF; Ali S; Ali IF; Philip PA; Abbruzzese J; Sarkar FH
    Cancer Res; 2006 Nov; 66(21):10553-9. PubMed ID: 17079479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
    Ali S; Banerjee S; Schaffert JM; El-Rayes BF; Philip PA; Sarkar FH
    J Cell Biochem; 2010 May; 110(1):171-81. PubMed ID: 20213764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines.
    El-Rayes BF; Ali S; Sarkar FH; Philip PA
    Mol Cancer Ther; 2004 Nov; 3(11):1421-6. PubMed ID: 15542781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
    Lu YY; Jing DD; Xu M; Wu K; Wang XP
    World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
    Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor.
    Gadgeel SM; Ali S; Philip PA; Ahmed F; Wozniak A; Sarkar FH
    Cancer; 2007 Dec; 110(12):2775-84. PubMed ID: 17948911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.
    Larbouret C; Gaborit N; Chardès T; Coelho M; Campigna E; Bascoul-Mollevi C; Mach JP; Azria D; Robert B; Pèlegrin A
    Neoplasia; 2012 Feb; 14(2):121-30. PubMed ID: 22431920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous blockage of epidermal growth factor receptor and cyclooxygenase-2 in a human xenotransplanted lung cancer model.
    Mu XY; Dong XL; Sun J; Ni YH; Dong Z; Li XL; Sun EL; Yi Z; Li G
    Asian Pac J Cancer Prev; 2014; 15(1):69-73. PubMed ID: 24528083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
    Qorri B; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells.
    Zhang Y; Banerjee S; Wang ZW; Marciniak DJ; Majumdar AP; Sarkar FH
    Cancer Res; 2005 May; 65(9):3877-82. PubMed ID: 15867387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
    Shin DM; Zhang H; Saba NF; Chen AY; Nannapaneni S; Amin AR; Müller S; Lewis M; Sica G; Kono S; Brandes JC; Grist WJ; Moreno-Williams R; Beitler JJ; Thomas SM; Chen Z; Shin HJ; Grandis JR; Khuri FR; Chen ZG
    Clin Cancer Res; 2013 Mar; 19(5):1244-56. PubMed ID: 23422093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
    Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
    World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity.
    Buck E; Eyzaguirre A; Haley JD; Gibson NW; Cagnoni P; Iwata KK
    Mol Cancer Ther; 2006 Aug; 5(8):2051-9. PubMed ID: 16928826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach.
    Lange F; Rateitschak K; Kossow C; Wolkenhauer O; Jaster R
    World J Gastroenterol; 2012 Nov; 18(43):6226-34. PubMed ID: 23180942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of simultaneously blocking target epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2 on the growth of NPC cell].
    Li SS; Zhang X; Xu J; Xie L; Qiu Y; Shu X; Tian Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Sep; 23(18):817-20, 823. PubMed ID: 20120857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2.
    Liu JF; Zhu GJ; Jamieson GG; Wu TC; Zhu TN; Shan BE; Drew PA
    Cancer Invest; 2009 Jan; 27(1):17-23. PubMed ID: 19160097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.